Literature DB >> 1310599

Mastoparan promotes exocytosis and increases intracellular cyclic AMP in human platelets. Evidence for the existence of a Ge-like mechanism of secretion.

C P Wheeler-Jones1, T Saermark, V V Kakkar, K S Authi.   

Abstract

Recent studies have shown that mastoparan, an amphiphilic peptide derived from wasp venom, accelerates guanine nucleotide exchange and GTPase activity of purified GTP-binding proteins. In the present study we have examined the functional consequences of exposure of intact human platelets to mastoparan. Mastoparan promoted rapid (less than or equal to 1 min) dose-dependent increases in 5-hydroxy[14C]tryptamine and beta-thromboglobulin release from dense-granule and alpha-granule populations respectively. The exocytotic response did not result from a lytic effect of mastoparan and occurred in the complete absence of platelet shape change and aggregation. Liberation of [3H]arachidonate and increases in cytosolic [Ca2+] (detected with fura 2) were not observed in platelets stimulated with mastoparan. Similarly, in platelets preloaded with [3H]inositol during reversible electroporation, mastoparan did not cause the accumulation of [3H]inositol phosphates. Mastoparan-induced secretion was unaffected by preincubation with either the protein kinase C inhibitor staurosporine (10 nM-10 microM) or prostacyclin (PGI2; 100 ng/ml) and was not accompanied by phosphorylation of the 45 kDa protein kinase C substrate or the 20 kDa protein normally associated with platelet activation. The G-protein inhibitor guanosine 5'-[beta-thio]diphosphate (GDP[S]; 1 mM) attenuated the secretion induced by mastoparan in both intact and saponin-permeabilized platelets. Encapsulation of GDP[S] during reversible permeabilization inhibited mastoparan-induced secretion, providing evidence for an intracellular action of GDP[S]. In all these studies thrombin (0.05-0.2 unit/ml) elicited characteristic responses, and thrombin-induced secretion was inhibited by staurosporine, PGI2 and GDP[S]. Mastoparan also increased intra-platelet cyclic AMP in a dose-dependent manner. Mastoparan and PGI2 increased 32P incorporation into a protein of approx. 24 kDa, whereas phosphorylation of a 50 kDa substrate was only seen in PGI2-stimulated platelets. These results indicate that mastoparan promotes secretion by a mechanism which does not involve stimulation of phospholipase C and suggest that the secretory event may result either from a direct fusogenic action of mastoparan and/or from stimulation of the putative exocytosis-linked G-protein, Ge.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310599      PMCID: PMC1130708          DOI: 10.1042/bj2810465

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  A new mast cell degranulating peptide "mastoparan" in the venom of Vespula lewisii.

Authors:  Y Hirai; T Yasuhara; H Yoshida; T Nakajima; M Fujino; C Kitada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1979-08       Impact factor: 1.645

2.  Action of guanosine 5'-[beta-thio]diphosphate on thrombin-induced activation and Ca2+ mobilization in saponin-permeabilized and intact human platelets.

Authors:  K S Authi; G H Rao; B J Evenden; N Crawford
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

3.  Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins).

Authors:  T Higashijima; S Uzu; T Nakajima; E M Ross
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

4.  Inhibition of calmodulin activity by insect venom peptides.

Authors:  M S Barnette; R Daly; B Weiss
Journal:  Biochem Pharmacol       Date:  1983-10-01       Impact factor: 5.858

5.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

6.  Ni-mediated inhibition of human platelet adenylate cyclase by thrombin.

Authors:  K Aktories; K H Jakobs
Journal:  Eur J Biochem       Date:  1984-12-03

7.  1,2-Dioctanoylglycerol but not 1-oleoyl-2-acetylglycerol inhibits agonist-induced platelet responses. Dependence of effects on extent of 45-kDa protein phosphorylation and agonist type.

Authors:  S Krishnamurthi; S Joseph; V V Kakkar
Journal:  Eur J Biochem       Date:  1987-09-15

8.  Facilitation of phospholipase A2 activity by mastoparans, a new class of mast cell degranulating peptides from wasp venom.

Authors:  A Argiolas; J J Pisano
Journal:  J Biol Chem       Date:  1983-11-25       Impact factor: 5.157

9.  A protein binding assay for adenosine 3':5'-cyclic monophosphate.

Authors:  A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

10.  ATP depletion in human platelets caused by permeabilization with saponin does not prevent serotonin secretion induced by collagen.

Authors:  M Ruggiero; T P Zimmerman; E G Lapetina
Journal:  Biochem Biophys Res Commun       Date:  1985-09-16       Impact factor: 3.575

View more
  8 in total

1.  Identification of 14-3-3 proteins in human platelets: effects of synthetic peptides on protein kinase C activation.

Authors:  C P Wheeler-Jones; M P Learmonth; H Martin; A Aitken
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

Review 2.  Helminthes and insects: maladies or therapies.

Authors:  Nora L El-Tantawy
Journal:  Parasitol Res       Date:  2014-12-30       Impact factor: 2.289

3.  Increased expression of procoagulant activity on the surface of human platelets exposed to heavy-metal compounds.

Authors:  C A Goodwin; C P Wheeler-Jones; S Namiranian; S Bokkala; V V Kakkar; K S Authi; M F Scully
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

4.  The effects of mastoparan on the carrot cell plasma membrane polyphosphoinositide phospholipase C.

Authors:  M H Cho; Z Tan; C Erneux; S B Shears; W F Boss
Journal:  Plant Physiol       Date:  1995-03       Impact factor: 8.340

5.  Correlation between secretion and phospholipase D activation in differentiated HL60 cells.

Authors:  J Stutchfield; S Cockcroft
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

6.  Effects of mastoparan upon the late stages of the ACTH secretory pathway of AtT-20 cells.

Authors:  B W McFerran; S B Guild
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

7.  Identification of the thiol isomerase-binding peptide, mastoparan, as a novel inhibitor of shear-induced transforming growth factor β1 (TGF-β1) activation.

Authors:  Teresa M Brophy; Barry S Coller; Jasimuddin Ahamed
Journal:  J Biol Chem       Date:  2013-03-05       Impact factor: 5.157

8.  Ca(2+)-independent fusion of secretory granules with phospholipase A2-treated plasma membranes in vitro.

Authors:  T Nagao; T Kubo; R Fujimoto; H Nishio; T Takeuchi; F Hata
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.